Latest Biosimilar Stories
WASHINGTON, Jan. 20, 2015 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) announced today that Ralph G.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Mitsubishi Gas Chemical
PORTLAND, Oregon, January 15, 2015 /PRNewswire/ -- A new report by Allied Market Research titled, "Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography)
LAKE FOREST, Ill., Jan.
Increased Competition Lowers Drug Costs Washington D.C.
Increased Competition Lowers Drug Costs WASHINGTON, Jan.
Today, NCPDP addressed the FDA, CDER and ODAC meeting that met to review and make a recommendation on what may be the first biosimilar to receive FDA approval in the U.S., and potentially develop
New report from Kantar Health shows opportunities for biosimilars are high in oncology, low in rheumatoid arthritis in China. Shanghai, China (PRWEB) December
- A person in a secondary role, specifically the second most important character (after the protagonist).